Dose Adjustment Recommendations for Generalized Anxiety Disorder

Rationale for Dose Reduction

• The European Society of Cardiology recommends reducing the dose of escitalopram (Lexapro) from 40 mg daily to 20 mg daily for generalized anxiety disorder, as doses above 20 mg daily may increase the risk of adverse effects, particularly QT interval prolongation 1

Safety Concerns at Higher Doses

• Both the FDA and EMA have limited the maximum recommended doses of escitalopram due to QT interval prolongation risk, with regulatory agencies specifically restricting maximum dosing to reduce cardiac risk 1
• The risk of cardiac arrest is increased with SSRI treatment, particularly in older patients, with a mean age of 74 years in registry studies 1

Recommended Dosing Algorithm

• The American College of Cardiology recommends starting at 10 mg daily, then increasing to 20 mg daily after one week if tolerated, with the 20 mg dose shown to be as effective as 60 mg daily when given once daily 2

Special Population Considerations

• For patients older than 60 years, the maximum recommended dose is further reduced due to increased sensitivity to adverse effects and cardiac risks 1
• In elderly patients with anxiety disorders, lower doses (10-20 mg daily) are preferred due to increased sensitivity to adverse effects and cardiac risks 1

Common Pitfalls to Avoid

• The European Heart Journal recommends obtaining a baseline ECG in patients over 40 years or with cardiac history before continuing treatment, and not ignoring cardiac risk factors 1
• The European Heart Journal also recommends not combining escitalopram with other QT-prolonging medications without careful monitoring 1